Long Path Partners’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
Other funds holding MLAB
RIM
Long Path Partners's MLAB Position: Q2 2026 in Review
Long Path Partners increased its Mesa Laboratories (MLAB) stake by 18% in Q2 2026, buying an estimated $7.2M and bringing the position to 477,126 shares worth $47.5M. The position accounts for 20.24% of the portfolio, ranked #2.
Long Path Partners first reported a position in MLAB in Q4 2025 and has held it in 3 quarters since. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.
- Long Path Partners held 477,126 shares of Mesa Laboratories worth $47.5M as of Q2 2026.
- Long Path Partners bought 71,543 Mesa Laboratories shares in Q2 2026, an estimated $7.2M.
- Mesa Laboratories made up 20.24% of Long Path Partners's portfolio in Q2 2026, its #2 holding.
- Long Path Partners first reported a position in Mesa Laboratories in Q4 2025 and has held it in 3 quarters since.
- 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.
Based on Long Path Partners's 13F filing for Q2 2026, filed 31 Jul 2026.